GLP-1 Drugs for PMOS Show Promise for Weight Loss and Hormone Balance
Multiple research studies have found that individuals using GLP-1 medications experienced greater weight loss, in addition to reductions in their insulin and testosterone levels. Recent studies indicate that GLP-1 drugs, which are already commonly utilized for weight control, might also benefit women suffering from polyendocrine metabolic ovarian syndrome (PMOS), previously recognized as polycystic ovary syndrome … Read more